Nuclear Entry of CRTC1 as Druggable Target of Acquired Pigmentary Disorder

Conclusion: We propose the targeting of CRTC1 as a unique strategy in the treatment of acquired pigmentary disorders.

Source: Theranostics - June 13, 2019 Category: Molecular Biology Authors: Cheong-Yong Yun, Seung Deok Hong, Young Hee Lee, Jiyeon Lee, Da-Eun Jung, Ga Hyun Kim, Song-Hee Kim, Jae-Kyung Jung, Ki Ho Kim, Heesoon Lee, Jin Tae Hong, Sang-Bae Han, Youngsoo Kim Tags: Research Paper Source Type: research